Clinical and molecular characterization of myotonia congenita using whole-exome sequencing in Egyptian patients.
CLCN1
SCN4A
Egypt
Myotonia Congenita
Variant
WES
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
15 Jun 2024
15 Jun 2024
Historique:
received:
28
03
2024
accepted:
16
05
2024
medline:
15
6
2024
pubmed:
15
6
2024
entrez:
14
6
2024
Statut:
epublish
Résumé
Myotonia Congenita (MC) is a rare disease classified into two major forms; Thomsen and Becker disease caused by mutations in the CLCN1 gene, which affects muscle excitability and encodes voltage-gated chloride channels (CLC-1). While, there are no data regarding the clinical and molecular characterization of myotonia in Egyptian patients. Herein, we report seven Egyptian MC patients from six unrelated families. Following the clinical diagnosis, whole-exome sequencing (WES) was performed for genetic diagnosis. Various in silico prediction tools were utilized to interpret variant pathogenicity. The candidate variants were then validated using Sanger sequencing technique. In total, seven cases were recruited. The ages at the examination were ranged from eight months to nineteen years. Clinical manifestations included warm-up phenomenon, hand grip, and percussion myotonia. Electromyography was performed in all patients and revealed myotonic discharges. Molecular genetic analysis revealed five different variants. Of them, we identified two novel variants in the CLCN1 gene ( c.1583G > C; p.Gly528Ala and c.2203_2216del;p.Thr735ValfsTer57) and three known variants in the CLCN1 and SCN4A gene. According to in silico tools, the identified novel variants were predicted to have deleterious effects. As the first study to apply WES among Egyptian MC patients, our findings reported two novel heterozygous variants that expand the CLCN1 mutational spectrum for MC diagnosis. These results further confirm that genetic testing is essential for early diagnosis of MC, which affects follow-up treatment and prognostic assessment in clinical practice.
Sections du résumé
BACKGROUND
BACKGROUND
Myotonia Congenita (MC) is a rare disease classified into two major forms; Thomsen and Becker disease caused by mutations in the CLCN1 gene, which affects muscle excitability and encodes voltage-gated chloride channels (CLC-1). While, there are no data regarding the clinical and molecular characterization of myotonia in Egyptian patients.
METHODS
METHODS
Herein, we report seven Egyptian MC patients from six unrelated families. Following the clinical diagnosis, whole-exome sequencing (WES) was performed for genetic diagnosis. Various in silico prediction tools were utilized to interpret variant pathogenicity. The candidate variants were then validated using Sanger sequencing technique.
RESULTS
RESULTS
In total, seven cases were recruited. The ages at the examination were ranged from eight months to nineteen years. Clinical manifestations included warm-up phenomenon, hand grip, and percussion myotonia. Electromyography was performed in all patients and revealed myotonic discharges. Molecular genetic analysis revealed five different variants. Of them, we identified two novel variants in the CLCN1 gene ( c.1583G > C; p.Gly528Ala and c.2203_2216del;p.Thr735ValfsTer57) and three known variants in the CLCN1 and SCN4A gene. According to in silico tools, the identified novel variants were predicted to have deleterious effects.
CONCLUSIONS
CONCLUSIONS
As the first study to apply WES among Egyptian MC patients, our findings reported two novel heterozygous variants that expand the CLCN1 mutational spectrum for MC diagnosis. These results further confirm that genetic testing is essential for early diagnosis of MC, which affects follow-up treatment and prognostic assessment in clinical practice.
Identifiants
pubmed: 38877370
doi: 10.1007/s11033-024-09646-8
pii: 10.1007/s11033-024-09646-8
doi:
Substances chimiques
Chloride Channels
0
CLC-1 channel
0
SCN4A protein, human
0
NAV1.4 Voltage-Gated Sodium Channel
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
766Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Gilitwala Z, Satpute S, Patil S (2023) A detailed clinical approach to non-dystrophic myotonia: a case report of two brothers with myotonia congenita. Cureus. https://doi.org/10.7759/cureus.40869
doi: 10.7759/cureus.40869
pubmed: 37489215
pmcid: 10290524
Stunnenberg BC, LoRusso S, Arnold WD et al (2020) Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle Nerve 62:430–444
doi: 10.1002/mus.26887
pubmed: 32270509
pmcid: 8117169
Chapman AM, Schurer M, Weijers L et al (2021) Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel. BMC Neurol 21:467. https://doi.org/10.1186/s12883-021-02491-3
doi: 10.1186/s12883-021-02491-3
pubmed: 34852780
pmcid: 8633892
Jitpimolmard N, Matthews E, Fialho D (2020) treatment updates for neuromuscular channelopathies. Curr Treat Opti Neurol 22:34. https://doi.org/10.1007/s11940-020-00644-2
doi: 10.1007/s11940-020-00644-2
Elizabeth S. Bryan; Mahdi Alsaleem (2022). Myotonia Congenita, StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; Aug 29. PMID: 32966006, Bookshelf ID: NBK562335
Thomsen J (1876) Tonische kraempfe in willkuerlich beweglichen muskeln in folge von ererbter psychischer disposition: ataxia muscularis? Arch Psychiat Nervenkr 6:702–718
doi: 10.1007/BF02164912
Emery AE (1991) Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscular Disord 1:19–29
doi: 10.1016/0960-8966(91)90039-U
Chand A, Chhuttani PN (1945) Myotonia congenita (Thomsen’s disease). Ind Med Gaz 80:350
pubmed: 21007261
pmcid: 5217994
Becker PE (1979) Heterozygote manifestation in recessive generalized myotonia. Hum Genet 46:325–329
doi: 10.1007/BF00273316
pubmed: 437775
Cherian A, Baheti NN, Kuruvilla A (2008) Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol 11:20–27. https://doi.org/10.4103/0972-2327.40221
doi: 10.4103/0972-2327.40221
pubmed: 19966974
pmcid: 2781140
Trip J, Drost G, Verbove DJ et al (2008) In a tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia. Eur J Hum Genet 16:921–929
doi: 10.1038/ejhg.2008.39
pubmed: 18337730
Orsini C, Petillo R, D’Ambrosio P et al (2020) CLCN1 molecular characterization in 19 South-italian patients with dominant and recessive type of myotonia congenita. Front Neurol 6(11):63. https://doi.org/10.3389/fneur.00063.PMID:32117024;PMCID:PMC7016095
doi: 10.3389/fneur.00063.PMID:32117024;PMCID:PMC7016095
Tang CY, Chen TY. (2011). Physiology and pathophysiology of CLC-1: mechanisms of a chloride channel disease, myotonia. J Biomed Iotechnol. 685328.
Imbrici P, Altamura C, Pessia M, Mantegazza R, Desaphy JF, Camerino DC (2015) ClC-1 chloride channels: state-of-the-art research and future challenges. Front Cell Neurosci 9:156. https://doi.org/10.3389/fncel.2015.00156
doi: 10.3389/fncel.2015.00156
pubmed: 25964741
pmcid: 4410605
Cannon SC (2018) Sodium channelopathies of skeletal muscle. Handb Exp Pharmacol 246:309–330. https://doi.org/10.1007/164_2017_52
doi: 10.1007/164_2017_52
pubmed: 28939973
pmcid: 5866235
Yang-Qi Xu, Liu X-L, Huang X-J, Tian W-T, Tang H-D, Cao Li (2018) Novel mutations in SCN4A gene cause myotonia congenita with scoliosis. Chinese Med J 131(4):477–479
doi: 10.4103/0366-6999.225061
Musa NH, Thilakavathy K, Mohamad NA et al (2023) Case report: incomplete penetrance of autosomal dominant myotonia congenita caused by a CLCN1 variant c.1667T>A (p. I556N) rare in a Malaysian family. Front Genet. https://doi.org/10.3389/fgene.2022.972007
doi: 10.3389/fgene.2022.972007
pubmed: 36659963
pmcid: 9842662
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
doi: 10.1093/nar/16.3.1215
pubmed: 3344216
pmcid: 334765
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30
doi: 10.1038/gim.2015.30
pubmed: 25741868
pmcid: 4544753
Elaraby NM, Ahmed HA, Ashaat NA et al (2022) Expanding the Phenotypic spectrum of APMR4 syndrome caused by a novel variant in LSS gene and review of literature. J Mol Neurosis 72:2242–2251. https://doi.org/10.1007/s12031-022-02074-y
doi: 10.1007/s12031-022-02074-y
Timothy M (2008) Differential diagnosis of myotonic disorders. Muscle Nerve 37:293–299. https://doi.org/10.1002/mus.20923
doi: 10.1002/mus.20923
Trivedi JR, Bundy B, Statland J et al (2013) Non-dystrophic myotonia: a prospective study of objective and patient-reported outcomes. Brain 136:2189–2200. https://doi.org/10.1093/brain/awt133
doi: 10.1093/brain/awt133
pubmed: 23771340
pmcid: 3692030
Papponen H, Toppinen T, Baumann P, Myllyl ̈a, V., Leisti, J., Kuivaniemi, H., Tromp, G., Myllyl ̈a, R. (1999) Founder mutations and the high prevalence of myotonia congenita in northern Finland. Neurology 53(2):297–302
doi: 10.1212/WNL.53.2.297
pubmed: 10430417
Sun C, Tranebjaerg L, Torbergsen T, Holmgren G, Van Ghelue M (2001) Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. European J Human Genet 9(12):903–909
doi: 10.1038/sj.ejhg.5200736
Dupré N, Chrestian N, Bouchard JP et al (2009) Clinical, electrophysiologic, and genetic study of nondystrophic myotonia in French-Canadians. Neuromuscul Disord 19:330–334
doi: 10.1016/j.nmd.2008.01.007
pubmed: 18337100
Colding-Jørgensen E (2005) Phenotypic variability in myotonia congenita. Muscle Nerve 32:19–34
doi: 10.1002/mus.20295
pubmed: 15786415
Mailänder V, Heine R, Deymeer F, Lehmann-Horn F (1996) Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet 58:317–324
pubmed: 8571958
pmcid: 1914535
Fialho D, Kullman DM, Hanna MG, Schorge S (2008) Non-genomic effects of sex hormones on ClC-1 may contribute to gender differences in myotonia congenita. Neuromuscul Disord 18:869–872
doi: 10.1016/j.nmd.2008.07.004
pubmed: 18815035
Li L, McCall C, Hu X (2020) Editorial: innate immunity programming and memory in resolving and non-resolving inflammation. Front Immunol 11:177
doi: 10.3389/fimmu.2020.00177
pubmed: 32117304
pmcid: 7026667
Morales F, Pusch M (2020) An up-to-date overview of the complexity of genotype-phenotype relationships in myotonic channelopathies. Front Neurol 10:507246
doi: 10.3389/fneur.2019.01404
Duno M, Vissing J (2021) Myotonia congenita. University of Washington, Seattle, Seattle (WA)
Orsini C, Petillo R, D’Ambrosio P, Ergoli M, Picillo E, Scutifero M, Passamano L, De Luca A, Politano L (2020) CLCN1 molecular characterization in 19 South-Italian patients with dominant and recessive type of myotonia congenita. Front Neurol 6(11):63
doi: 10.3389/fneur.2020.00063
Kubisch C, Schmidt-Rose T, Fontaine B, Bretag H, Jentsch TJ (1998) ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence. Human Mol Genet 7(11):1753–1760
doi: 10.1093/hmg/7.11.1753
Plassart-Schiess E, Gervais A, Eymard B et al (1998) Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. Neurology 50(4):1176–1179. https://doi.org/10.1212/WNL.50.4.1176
doi: 10.1212/WNL.50.4.1176
pubmed: 9566422
Fialho D, Schorge S, Pucovska U et al (2007) Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain 130(12):3265–3274
doi: 10.1093/brain/awm248
pubmed: 17932099
Suetterlin K, Matthews E, Sud R, McCall S, Fialho D, Burge J, Jayaseelan D, Haworth A, Sweeney MG, Kullmann DM, Schorge S, Hanna MG, Männikkö R (2022) Translating genetic and functional data into clinical practice: a series of 223 families with myotonia. Brain 145(2):607–620. https://doi.org/10.1093/brain/awab344.PMID:34529042;PMCID:PMC9014745
doi: 10.1093/brain/awab344.PMID:34529042;PMCID:PMC9014745
pubmed: 34529042
Milla CP, De Castro CP, Gómez-González C et al (2019) Myotonia congenita: mutation spectrum of CLCN1 in Spanish patients. J Genet 98:71
doi: 10.1007/s12041-019-1115-0
pubmed: 31544778
Bednarz M, Stunnenberg BC, Kusters B et al (2017) A novel Ile1455Thr variant in the skeletal muscle sodium channel alpha-subunit in a patient with a severe adult-onset proximal myopathy with electrical myotonia and a patient with mild paramyotonia phenotype. Neuromuscul Disord 27(2):175–182. https://doi.org/10.1016/j.nmd.2016.09.023
doi: 10.1016/j.nmd.2016.09.023
pubmed: 28024841
Westra D, Schouten MI, Stunnenberg BC et al (2019) Panel-based exome sequencing for neuromuscular disorders as a diagnostic service. J Neuromuscul Dis 6(2):241–258. https://doi.org/10.3233/JND-180376
doi: 10.3233/JND-180376
pubmed: 31127727
Stunnenberg BC, Raaphorst J, Deenen JCW et al (2018) Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. Neuromuscul Disord 28(5):402–407. https://doi.org/10.1016/j.nmd.2018.03.006
doi: 10.1016/j.nmd.2018.03.006
pubmed: 29606556
Tincheva S, Georgieva B, Todorov T et al (2016) Myotonia congenita type becker in Bulgaria: First genetically proven cases and mutation screening of two presumable endemic regions. Neuromuscul Disord 26(10):675–680. https://doi.org/10.1016/j.nmd.2016.08.001
doi: 10.1016/j.nmd.2016.08.001
pubmed: 27614575
Moon IS, Kim HS, Shin JH et al (2009) Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita. J Korean Med Sci 24(6):1038–1044
doi: 10.3346/jkms.2009.24.6.1038
pubmed: 19949657
pmcid: 2775849
Araújo CET, Oliveira CMC, Barbosa JD et al (2019) A large intragenic deletion in the CLCN1 gene causes hereditary myotonia in pigs. Sci Rep 9(1):15632. https://doi.org/10.1038/s41598-019-51286-7
doi: 10.1038/s41598-019-51286-7
pubmed: 31666547
pmcid: 6821760
Lueck JD, Lungu C, Mankodi A et al (2007) Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am J Physiol Cell Physiol 292:C1291–C1297. https://doi.org/10.1152/ajpcell.00336.2006
doi: 10.1152/ajpcell.00336.2006
pubmed: 17135300
Papponen H, Nissinen M, Kaisto T et al (2008) F413C and A531V but not R894X myotonia congenita mutations cause defective endoplasmic reticulum export of the muscle-specific chloride channel CLC-1. Muscle Nerve 37:317–325. https://doi.org/10.1002/mus.20922
doi: 10.1002/mus.20922
pubmed: 17990293
Weinberger S, Wojciechowski D, Sternberg D et al (2012) Disease-causing mutations C277R and C277Y modify gating of human ClC-1 chloride channels in myotonia congenita. J Physiol 590:3449–3464. https://doi.org/10.1113/jphysiol.2012.232785
doi: 10.1113/jphysiol.2012.232785
pubmed: 22641783
pmcid: 3547262
Jurkat-Rott K, Holzherr B, Fauler M, Lehmann-Horn F (2010) Sodium channelopathies of skeletal muscle result from gain or loss of function. Pflugers Arch 460:239–248. https://doi.org/10.1007/s00424-010-0814-4
doi: 10.1007/s00424-010-0814-4
pubmed: 20237798
pmcid: 2883924
Cannon SC (2015) Channelopathies of skeletal muscle excitability. Compr Physiol 5:761–790. https://doi.org/10.1002/cphy.c140062
doi: 10.1002/cphy.c140062
pubmed: 25880512
pmcid: 4754081
Stenson PD, Ball EV, Mort M et al (2003) Human gene mutation database (HGMD). Hum Mutat 2003(21):577–581. https://doi.org/10.1002/humu.10212
doi: 10.1002/humu.10212
Kubota T, Roca X, Kimura T et al (2011) A mutation in a rare type of intron in a sodium-channel gene results in aberrant splicing and causes myotonia. Hum Mutat 32:773–782. https://doi.org/10.1002/humu.21501
doi: 10.1002/humu.21501
pubmed: 21412952
pmcid: 4109284
World Health Organization (WHO) (2015) Cooperation: CIOMS-a nongovernmental organization in official relations with WHO. WHO Drug Inf 29(4):435–439
Metwally AM, Amer HA, Salama HI et al (2021) Egyptian patients’/guardians’ experiences and perception about clinical informed consent and its purpose: cross sectional study. PLoS ONE 16(6):e0252996
doi: 10.1371/journal.pone.0252996
pubmed: 34125842
pmcid: 8202917